Thymosin Alpha-1 Research Peptide

Thymosin Alpha-1 peptide UK is Crown Peptides’ synthetic 28-amino-acid thymic peptide, supplied in 5mg and 10mg vials for laboratory research into T-cell maturation, dendritic-cell biology and immune signalling.

Key Features

• Synthetic 28-amino-acid thymic peptide, 5mg and 10mg vials
• Studied in research involving T-cell maturation and signalling
• Studied in research involving innate and adaptive immune responses
• Studied in research involving dendritic-cell and toll-like-receptor research
• Studied in research involving cytokine and immune-modulation pathways
• Batch-specific quality documentation available

About Thymosin Alpha-1 Peptide UK

Thymosin Alpha-1 is a 28-amino-acid peptide originally identified from thymic peptide preparations. It is widely used in immunology research because experimental work has linked it with T-cell function, dendritic-cell signalling and interactions between innate and adaptive immune pathways.

Thymosin Alpha-1 Research

Thymosin Alpha-1 research includes T-cell maturation and activation, dendritic-cell biology, toll-like receptor pathways, cytokine signalling and immune responses to experimental infectious or inflammatory challenges, including documented activation of dendritic cells through toll-like-receptor signalling (Learn more). Its research profile is broader than simple immune stimulation, with studies examining how it can modulate different arms of immune signalling depending on context, alongside related host-defence and immune-research peptides such as [LL-37] and [KPV]. Researchers should distinguish this research context from any therapeutic or clinical framing.

• T-cell maturation and signalling
• Innate and adaptive immune responses
• Dendritic-cell and toll-like-receptor research
• Cytokine and immune-modulation pathways

Research context: the Thymosin Alpha-1 research areas described above reflect laboratory, preclinical or published scientific investigation. They should not be interpreted as established therapeutic effects, medical claims or approved human uses.

Specifications

• Product: Thymosin Alpha-1
• Classification: Synthetic 28-amino-acid thymic peptide
• Available form: 5mg and 10mg vials
• Purity / assay: Batch-specific; refer to Certificate of Analysis
• Verification: HPLC and Mass Spectrometry where analytically appropriate
• Intended use: Laboratory research only

Purity and Testing

Crown Peptides Thymosin Alpha-1 is supplied for controlled laboratory research with batch-specific analytical documentation. High-Performance Liquid Chromatography (HPLC) can assess chromatographic purity, while Mass Spectrometry provides molecular information used to support identity verification. The batch-specific Certificate of Analysis is the definitive source for the exact purity result, identity data and analytical specification of the material supplied.

Storage Conditions

• Store unreconstituted material according to the product label and batch-specific documentation
• Prepared research solutions should use validated storage conditions appropriate to the compound and study design
• Protect from unnecessary heat, direct light and repeated temperature fluctuations

Research Use Only Disclaimer

• Laboratory research only
• Not for human or clinical use
• Not for human or veterinary consumption
• For handling by appropriately qualified personnel only

Additional Information

• Product Name: Thymosin Alpha-1
• Classification: Synthetic 28-amino-acid thymic peptide
• CAS Number: 62304-98-7
• Peptide length: 28 amino acids
• Available form: 5mg and 10mg vials
• Exact sequence and acetylation state should be matched to batch documentation

Thymosin Alpha-1 Frequently Asked Questions

What is Thymosin Alpha-1?
Thymosin Alpha-1 is a 28-amino-acid thymic peptide widely studied in immunology, supplied by Crown Peptides in 5mg and 10mg vials.

What is Thymosin Alpha-1 researched for?
Research includes T-cell biology, dendritic cells, toll-like receptor pathways, cytokine signalling and innate/adaptive immune responses.

Is Thymosin Alpha-1 the same as Thymosin beta-4?
No. They are distinct peptides with different sequences and research profiles.

Why is Thymosin Alpha-1 described as immunomodulatory in research?
Experimental studies examine changes across multiple immune pathways rather than a single one-directional immune effect.

How is Thymosin Alpha-1 verified?
HPLC and Mass Spectrometry can assess peptide identity and purity, with exact sequence/form and batch results documented on the CoA.

Related Compounds

Researchers working with Thymosin Alpha-1 may also be interested in [LL-37], [KPV], [TB-500], [ARA-290] and [Kisspeptin-10] — other immune and signalling-research peptides studied in related research areas.